Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pritelivir Ointment for Recurrent Herpes Labialis
NCT02871492Phase 2Completed
- Sponsor
- AiCuris
- Start
- Nov 2016
- Primary completion
- Sep 2017
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pritelivir in herpes labialis (3 arms), sponsored by AiCuris. Primary endpoint: Percentage of Subjects With Non-ulcerative Lesions Based on Principal Investigator's Assessment at 13 days. Started Nov 2016; status: completed.
02
Drugs
pritelivir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT02871492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871492.